Uso de clobazan en epilepsias de dificil control en niños

Campos O., Patricia

doi:10.1590/S0004-282X1993000100011

Resúmenes

Se presenta el estudio de 20 pacientes en edad pediátrica con diagnóstico de epilepsia de difícil control, en los cuales fue usado el clobazan como terapia anticonvulsivante coadyuvante, vistos entre Enero-1986 y Julio-1990 en el consultorio externo de Neuropediatría del Hospital General Base Cayetano Heredia y práctica privada, con un seguimiento entre 6 y 45 meses. La etad de inicio para la epilepsia fue en promedio 22 meses y la forma mas frecuente los síndromes de epilepsia generalizada, tanto secundaria como idiopática. Se obtuvo disminución de frecuencia de crisis en rango significativo en 60% de los pacientes con control completo en 35% del total, habiendose encontrado los mejores resultados en epilepsias generalizadas secundarias tipo Lennox-Gastaut y West. Se encontró fenómeno de tolerancia en 25% y efecto psicotrópico en tres pacientes. Sugerimos el uso de esta 1,5 ben-zodiazepina en epilepsias de difícil control en niños, en nuestro medio.

epilepsia; infancia; difícil controle; clobazan

We present the study of 20 pediatric patients with difficult controlled epilepsy in which we used clobazam as adjuvant anticonvulsant therapy between January 1986 and July 1990 at the outpatients neuropediatric facility of the Hospital General Base Cayetano Heredia and the private practice, with 6 to 45 months follow up. The mean age for the onset of the epilepsy was 22 months and the most frequent kind was the generalized epilepsy syndrome both secondary and idiopatic. It was obtained a significant decrease of seizures in 60% of the patients with a complete control in 35% of the total. It was found the best outcome in secondary generalized epilepsies Lennox-Gas taut and West types. It was found tolerance phenomenon in 25%, and psychotropic effect in three patients. We suggest the use of this 1,5 benzodiazepine drug in difficult controlled epilepsies in children of our region.

epilepsy; infancy; hard control; clobazam

Patricia Campos O.

Profesora Asociada, Departamento de Neurología, Universidad Peruana Cayetano Heredia, Lima

RESUMEN

Se presenta el estudio de 20 pacientes en edad pediátrica con diagnóstico de epilepsia de difícil control, en los cuales fue usado el clobazan como terapia anticonvulsivante coadyuvante, vistos entre Enero-1986 y Julio-1990 en el consultorio externo de Neuropediatría del Hospital General Base Cayetano Heredia y práctica privada, con un seguimiento entre 6 y 45 meses. La etad de inicio para la epilepsia fue en promedio 22 meses y la forma mas frecuente los síndromes de epilepsia generalizada, tanto secundaria como idiopática. Se obtuvo disminución de frecuencia de crisis en rango significativo en 60% de los pacientes con control completo en 35% del total, habiendose encontrado los mejores resultados en epilepsias generalizadas secundarias tipo Lennox-Gastaut y West. Se encontró fenómeno de tolerancia en 25% y efecto psicotrópico en tres pacientes. Sugerimos el uso de esta 1,5 ben-zodiazepina en epilepsias de difícil control en niños, en nuestro medio.

Palavras-chave: epilepsia, infancia, difícil controle, clobazan.

SUMMARY

We present the study of 20 pediatric patients with difficult controlled epilepsy in which we used clobazam as adjuvant anticonvulsant therapy between January 1986 and July 1990 at the outpatients neuropediatric facility of the Hospital General Base Cayetano Heredia and the private practice, with 6 to 45 months follow up. The mean age for the onset of the epilepsy was 22 months and the most frequent kind was the generalized epilepsy syndrome both secondary and idiopatic. It was obtained a significant decrease of seizures in 60% of the patients with a complete control in 35% of the total. It was found the best outcome in secondary generalized epilepsies Lennox-Gas taut and West types. It was found tolerance phenomenon in 25%, and psychotropic effect in three patients. We suggest the use of this 1,5 benzodiazepine drug in difficult controlled epilepsies in children of our region.

Key words: epilepsy, infancy, hard control, clobazam.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

Aceite: 05-março-1992.

Dra. Patricia Campos O. Neuropediatría, Hospital General Base Cayetano Heredia - Apartado 5045 - Lima - Perú.

1. Allen JW, Oxley J, Robertson MM, Trimble MR, Richens A, Jawad SM. Clobazam as adjuntive treatment in refractory epilepsy. Br Med J 1983, 286:1246-1247.
2. Bensch J, Blennow G, Ferngren H, Gamstorp I, Herrlin K-M, Kubista J, Arvidsson A, Dahlstrom H. A double-blind study of clonazepam in the treatment of therapy resistent epilepsy in children. Dev Med Child Neurol 1977, 19:335-342.
3. Callaghan N, Goggin I. Clobazam as adjuntive treatment in drug resistant epilepsy: report on an open prospective study. Ir Med J 1984, 77:240-244.
4. Comaggia CM, Cattabeni G, Cerisola N, Leozzapa C, Mascetti PL, Massironi R, Porro G, Manghi E. Intractable epilepsies: an open trial with clobazam. Acta Neurol 1989, 11:1-8.
5. Critchley E, Vakil SD, Hayward H, Owen M, Cocks A, Freewantle NP. Double-blind clinical trial of clobazam in refractory epilepsy. J R Soc Med 1981, 43:159-163.
6. Diez Cuervo A, Sanchez Caro J, Manrique M, Rodriguez Ramos P, Coullant JA, Perez Serrano J. Clobazan en politerapia de epilepsia de dificil control. Phronesis 1982, 3:53-58.
7. Dulac D, Figueroa D, Rey E, Arthuis M. Monotherapie par le clobazam dans les epilepsies de l'enfant. Presse Med 1983, 12:1067-1069.
8. Farrell K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 1986, 27 (Suppl 1): S45-S51.
9. Farrell K, Jan JE, Julian JV, Betts TA, Wong PK. Clobazam in children with intractables seizures. Epilepsia 1984, 25:657.
10. Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. Lancet 1982, 2:71-73,
11. Figueroa D, Adlerstein L, Manterola A. Clobazan en epilepsias refractarias del niño. Rev Chil Pediat 1984, 55:401-405.
12. Gastaut H. Proprietes antiepileptiques exceptionnelles et meconnues d'un anxiolytique du commerce, le clobazam. Concours Med 1978, 100:3697-3701.
13. Gastaut H, Low MD. Antiepileptic properties oí clobazam, a 1,5-benzodiazepine, in man. Epilepsia 1979, 20:437-446.
14. Gibbs F, Anderson E. Treatment of hipsarhythmia and infantile spams with a Librium analogue. Neurology 1965, 15:1173-1176.
15. Hanson RA, Menkes JH. A new anticonvulsant in the management of minor motor seizures. Dev Med Child Neurol 1972, 14:3-14.
16. Koeppen D, Baruzzi A, Capozza M, Chauvel P, Courjon J, Favel P, Lorenz H, Oiler Ferrer-Vidal L, Procaccianti G, Fucquoy-Ponsar M, Sallou C, Sideri G, Trettier S, Weber M, Wolf P. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study. Epilepsia 1987, 28:495-506.
17. Munn R, Camfield P, Camfield C, Dooley J. Clobazam for refractory childhood seizure disorders: a valuable supplementary drug. Can J Neurol Sci 1988, 15:406-408.
18. Pechandre JC, Beudin P, Devize JL, Gilbert J. Use of clobazam as antiepileptic in the Lennox-Gastaut syndrome. Encéphale 1981, 7:181-190.
19. Robertson M. Current status of the 1,4 and 1,5 benzodiazepines in the treatment of epilepsy: the place of clobazam. Epilepsia 1986, 27 (Suppl 1): S7-S41.
20. Scott DF, Moffett A. On the anticonvulsant and psychotropic properties of clobazam: a preliminary study. Epilepsia 1986, 27 (Suppl 1): S42-S44.
21. Shimizu H, Abej, Futagi Y, Onoe S, Tagawa T, Mimaki T, Yamatodani A, Kato M, Kamio M, Sumi K, Sugita T, Yabuuchi H. Antiepileptic effects of clobazam in children. Brain Dev 1982, 4:57-62.
22. Tinuper P, Aguglia O, Gastaut H. Use of clobazam in certain forms of status epilepticus and in startle-induced epileptic seizures. Epilepsia 1986, 27 (Suppl 1): S18-S26.
23. Trimble MR, Thompson PJ. Anticonvulsant drugs: cognitive functions and behavior. Epilepsia 1983, 24 (Suppl 1) S55-S63.